As new findings emerge, what do we know about cannabis and diabetes so far?
Recent studies find CBD may help curb opioid cravings and enhance the effects of the opioid antidote, naloxone.
A new case study highlights the potential of cannabis for improving quality of life in patients with neuropathic pain.
The Cannabis Industry Council (CIC), has called on the ACMD to recommend to the Home Office that cannabis be rescheduled for research purposes.
Advocates in the UK are calling for their own government to follow suit and invest in much-needed NHS trials.
One in two patients were prescribed medicinal cannabis for chronic pain, with a quarter taking it to treat mental health conditions.
Researchers identified a ‘significant decrease’ in financial interactions between opioid manufacturers and physicians as an effect of medical cannabis legalisation.
Around 60% of patients with Parkinson’s disease and multiple sclerosis said cannabis was beneficial at managing their symptoms.
Black babies were disproportionately more likely to be drug tested than White, before and after cannabis legalisation.
How can cannabis help manage symptoms of endometriosis and potentially treat the condition?